8th EU Pharma Regulatory Law conference
2013 has presented a unique set of challenges to the pharmaceutical industry. Transparency is becoming ever more prevalent in all aspects of the regulatory process, regulatory bodies are sanctioning drug companies unlike ever before, competitors are using new strategies to gain possession of your best-kept secrets, the impact of technology continues to grow, and new legislation is coming into force which will alter the playing field for everyone. C5's EU Pharma Regulatory Law conference will focus on the practical solutions to the current challenges facing pharma companies, legal practitioners, and regulatory and compliance officers. You will hear the specific strategies used by industry experts in dealing with regulatory challenges in 2013, which will impact your company in 2014 and beyond.